Your browser doesn't support javascript.
loading
Tuberculosis following programmed cell death receptor-1 (PD-1) inhibitor in a patient with non-small cell lung cancer. Case report and literature review.
Suliman, Aasir M; Bek, Shaza A; Elkhatim, Mohamed S; Husain, Ahmed A; Mismar, Ahmad Y; Eldean, M Z Sharaf; Lengyel, Zsolt; Elazzazy, Shereen; Rasul, Kakil I; Omar, Nabil E.
Afiliação
  • Suliman AM; Department of internal medicine, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
  • Bek SA; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
  • Elkhatim MS; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
  • Husain AA; Department of Infectious Diseases, Communicable Disease Center, Hamad Medical Corporation, Doha, Qatar.
  • Mismar AY; Department of internal medicine, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
  • Eldean MZS; Department of Pathology, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
  • Lengyel Z; Department of Body Imaging, National Centre for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
  • Elazzazy S; Pharmacy Department, National Centre for Cancer Care and Research, Hamad Medical Corporation, 3050, Doha, Qatar.
  • Rasul KI; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
  • Omar NE; Pharmacy Department, National Centre for Cancer Care and Research, Hamad Medical Corporation, 3050, Doha, Qatar. Nomar4@hamad.qa.
Cancer Immunol Immunother ; 70(4): 935-944, 2021 Apr.
Article em En | MEDLINE | ID: mdl-33070259
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Carcinoma Pulmonar de Células não Pequenas / Anticorpos Monoclonais Humanizados / Receptor de Morte Celular Programada 1 / Antineoplásicos Imunológicos / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Cancer Immunol Immunother Assunto da revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Qatar
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Carcinoma Pulmonar de Células não Pequenas / Anticorpos Monoclonais Humanizados / Receptor de Morte Celular Programada 1 / Antineoplásicos Imunológicos / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Cancer Immunol Immunother Assunto da revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Qatar